Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
ChinaBio® Today - Focused solely on China life science...
China is already the second largest and fastest growing pharmaceutical market in the world, and on track to become the #1 market by 2020. Now, after billions of dollars of investment, China is also becoming a world leader in innovation.
Our parent organization, ChinaBio® Group (www.ChinaBio.com), provides consulting services to major companies and leading investment organizations involved in the China life science industry, including Roche, Pfizer, Life Technolgoies, Shire and many others. Our capital group also provides funding to western companies wishing to access the China market. Our investment and partnering conferences are considered the premier events of they type in China, including our annual ChinaBio® Partnering Forum, ChinaBio® Leadership Retreat and ChinaBio® Investor Forum (see Upcoming Events).
Read more about Our Approach, Our Editors and Our Sponsors below...
ChinaBio® in the News